Latest Elevra Lithium (ASX:ELV) News

A tiny gold explorer, a battery materials stock and a biotech name led a week packed with dealmaking, drilling news and fresh funding. Resources did most of the heavy lifting, while several big gaps either held firm or gave back part of their early jump.

Elevra Lithium has commenced construction on its North American Lithium expansion, backed by a recent capital raise that fully funds the project. The expansion aims to boost spodumene concentrate output by up to 20% and reduce operating costs by mid-2027.

Capital raisings, resource updates and Medicare news drove the week’s biggest share moves. The sharpest gains came from silver and tungsten juniors, while the heaviest fall came from a deeply discounted equity raising.

Elevra Lithium has raised A$275 million through a fully underwritten institutional placement to fund its North American Lithium expansion and Moblan project development, supported by strong institutional demand.

Elevra Lithium's updated scoping study for its North American Lithium mine expansion reveals a faster ramp-up to 338 ktpa spodumene concentrate with stable costs and a significant increase in project value.

Elevra Lithium has struck a US$71 million deal to offload its Ghanaian Ewoyaa Project interest to Zhejiang Huayou Cobalt, pivoting its strategy firmly towards North American assets while shedding funding obligations tied to Ewoyaa.

Elevra Lithium delivered a strong March 2026 quarter with record revenues, operational improvements at North American Lithium, and progress on multiple growth fronts, supported by a robust cash position.

Rare earths and gold dominated the tape, with one small-cap rare earth explorer ripping more than 70% on a single drilling headline. Gold producers, meanwhile, kept turning high bullion prices into dividends, buy-backs and bigger balance sheets.

Elevra Lithium Limited reported an 8% revenue increase and a US$74 million profit for the first half of FY26, driven by higher lithium prices and strategic merger synergies. The company advances its North American Lithium expansion while managing temporary production challenges.

Small caps stole the spotlight, with a handful of stocks doubling on deal news and early-stage project updates. Large miners were steadier, but even they couldn’t fully escape the week’s sharp gap moves.

Elevra Lithium reported solid Q2 FY26 production and revenue results while progressing its North American Lithium brownfield expansion and forging strategic supply partnerships.

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.